Correlation Between IShares Medical and VanEck Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Medical and VanEck Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Medical and VanEck Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Medical Devices and VanEck Biotech ETF, you can compare the effects of market volatilities on IShares Medical and VanEck Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Medical with a short position of VanEck Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Medical and VanEck Biotech.

Diversification Opportunities for IShares Medical and VanEck Biotech

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between IShares and VanEck is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding iShares Medical Devices and VanEck Biotech ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VanEck Biotech ETF and IShares Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Medical Devices are associated (or correlated) with VanEck Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VanEck Biotech ETF has no effect on the direction of IShares Medical i.e., IShares Medical and VanEck Biotech go up and down completely randomly.

Pair Corralation between IShares Medical and VanEck Biotech

Considering the 90-day investment horizon iShares Medical Devices is expected to generate 0.91 times more return on investment than VanEck Biotech. However, iShares Medical Devices is 1.1 times less risky than VanEck Biotech. It trades about 0.06 of its potential returns per unit of risk. VanEck Biotech ETF is currently generating about 0.04 per unit of risk. If you would invest  5,840  in iShares Medical Devices on December 28, 2024 and sell it today you would earn a total of  182.00  from holding iShares Medical Devices or generate 3.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

iShares Medical Devices  vs.  VanEck Biotech ETF

 Performance 
       Timeline  
iShares Medical Devices 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Medical Devices are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong technical indicators, IShares Medical is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
VanEck Biotech ETF 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in VanEck Biotech ETF are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong fundamental drivers, VanEck Biotech is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

IShares Medical and VanEck Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Medical and VanEck Biotech

The main advantage of trading using opposite IShares Medical and VanEck Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Medical position performs unexpectedly, VanEck Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Biotech will offset losses from the drop in VanEck Biotech's long position.
The idea behind iShares Medical Devices and VanEck Biotech ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences